MAWI

AccurKardia and Mawi Announce Strategic Collaboration to Provide Automated ECG Analytics for the new Mawi Watch

Retrieved on: 
Wednesday, October 19, 2022
Health Technology, Health, Cardiology, Medical Devices, API, RPM, HRV, Heart rate, Life, Management of heart failure, Patient, Hospital, Blood pressure, Â, Photoplethysmogram, Infarction, Respiratory rate, Health, Holter, Stroke, PPG, CEO, AFIB Technology, Death, Solution, ECG, Medical device

As part of the collaboration, AccurKardias cutting edge innovation in device agnostic automated ECG analytics will complement Mawis proven expertise in designing, developing and deploying superior cardiac monitoring devices and wearables.

Key Points: 
  • As part of the collaboration, AccurKardias cutting edge innovation in device agnostic automated ECG analytics will complement Mawis proven expertise in designing, developing and deploying superior cardiac monitoring devices and wearables.
  • Joining forces will provide our new Mawi Watch with next level ECG analytics as we create a fully integrated solution for chronic patients cardiac remote monitoring, said Ron Fridman , the CEO of Mawi.
  • AccurKardia provides clinical-grade, device-agnostic, API-accessible automated ECG analytics to clinical and consumer-grade ECG devices, as well as telehealth and remote patient monitoring companies.
  • Mawi Watch comes with RPM software, which provides healthcare practitioners with real-time health data and high-risk alerts.

Mawi DNA Technologies Launches NextSWAB™ For Accurate, More Reliable COVID-19 Test Results

Retrieved on: 
Tuesday, May 10, 2022
Biotechnology, Health, Other Health, Medical Devices, COVID-19, Canadian Biosample Repository, Population, Patent, Efficiency, CEO, PCR, Geography, Collection, Temperature, RNA, Integrated DNA Technologies, Pharmaceutical industry, Sintering

Mawi DNA Technologies (Mawi), a medical device company focusing on the development of innovative technologies for biosampling, has launched the NextSWAB, a 100% medical-grade plastic swab designed and manufactured in the US.

Key Points: 
  • Mawi DNA Technologies (Mawi), a medical device company focusing on the development of innovative technologies for biosampling, has launched the NextSWAB, a 100% medical-grade plastic swab designed and manufactured in the US.
  • NextSWAB is currently optimized for nasal sample collection with validation for other sample types ongoing.
  • The NextSWAB sterile sampling applicator is six inches in length with a unique head design positioned at the distal end, said Dr. Bassam El-Fahmawi, CEO of Mawi.
  • Mawi DNA Technologies, founded in 2013, has developed and commercialized the iSWAB technology, an innovative system for collection of biosamples.